Psoriasis
Conditions
Keywords
Psoriasis
Brief summary
This is an observational, naturalistic, multicenter, retrospective study to describe the therapeutic management of patients with moderate and severe psoriasis under treatment with topical and/or systemic drugs in usual clinical practice in Spain.
Interventions
Sponsors
Wyeth is now a wholly owned subsidiary of Pfizer
Study design
Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Main Inclusion Criteria: ·Over 18 years of age.·Diagnosed with moderate or severe psoriasis.·Initiated treatment with topical and/or systemic treatment between two and five years before enrollment in the study. ·Has a clinical record at the dermatologist office. Main
Exclusion criteria
·Currently participating in a clinical study. ·Clinical record lacks minimum data required for observational analysis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Descriptive analysis of the therapeutic management of patients with moderate and severe psoriasis under treatment with topical and/or systemic drugs including sequence, doses and duration of treatment. | 4 months |
Secondary
| Measure | Time frame |
|---|---|
| Comparison of therapeutic management depending on patients' disease severity, using absolute and relative frequencies for qualitative variables and centralization and dispersion measures (mean, SD, median, minimum, maximum..) for quantitative variables. | 4 months |
Countries
Spain
Outcome results
None listed